Gefitinib

What Is Gefitinib?

Gefitinib is a targeted cancer therapy primarily used to treat non-small cell lung cancer (NSCLC). It belongs to a class of medications known as epidermal growth factor receptor (EGFR) inhibitors. By blocking the action of the EGFR protein, gefitinib helps to slow down or stop the growth of cancer cells that rely on this pathway for survival and proliferation. This medication is often prescribed for patients whose tumors have specific mutations in the EGFR gene, making it a personalized treatment option.

Uses of Gefitinib

Gefitinib is primarily approved for the treatment of:

• Non-Small Cell Lung Cancer (NSCLC): Specifically for patients with locally advanced or metastatic NSCLC who have tumors with EGFR mutations.
• First-Line Treatment: It is often used as a first-line treatment for patients with advanced NSCLC who have not received prior chemotherapy.
• Second-Line Treatment: Gefitinib may also be used in patients who have previously undergone chemotherapy and have experienced disease progression.

How It Works

Gefitinib works by inhibiting the activity of the epidermal growth factor receptor (EGFR), a protein found on the surface of some cells. In cancer cells, EGFR can become overactive, leading to uncontrolled cell growth and division. By blocking this receptor, gefitinib prevents the signals that promote cancer cell proliferation, effectively slowing down or stopping tumor growth. This targeted approach allows for a more focused treatment with potentially fewer side effects compared to traditional chemotherapy.

Dosage and Administration

The standard dosage of gefitinib for adults is typically 250 mg taken once daily. It is available in tablet form and should be taken with a full glass of water. Patients are advised to take gefitinib at the same time each day to maintain consistent levels of the medication in the body. For pediatric patients, the dosage may vary based on individual circumstances and should be determined by a healthcare provider.

Side Effects of Gefitinib

Common side effects of gefitinib include:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Fatigue
• Loss of appetite

Serious side effects may include:

• Liver problems (elevated liver enzymes)
• Severe skin reactions
• Eye problems (dry eyes, corneal ulcers)
• Interstitial lung disease (rare but potentially fatal)

Patients should report any severe or unusual symptoms to their healthcare provider immediately.

Drug Interactions

Gefitinib can interact with several medications and substances, including:

• CYP3A4 Inhibitors: Drugs that inhibit this enzyme can increase gefitinib levels, leading to increased side effects. Examples include ketoconazole and erythromycin.
• CYP3A4 Inducers: Medications that induce this enzyme can decrease gefitinib levels, reducing its effectiveness. Examples include rifampin and St. John's Wort.
• Antacids: Antacids or medications that significantly alter gastric pH (such as proton pump inhibitors and H? blockers) can reduce gefitinib absorption; spacing or avoidance may be recommended.

Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.

Benefits of Gefitinib

The use of gefitinib offers several clinical advantages:

• Targeted Therapy: Gefitinib specifically targets cancer cells with EGFR mutations, potentially leading to better outcomes compared to traditional chemotherapy.
• Oral Administration: Being an oral medication, gefitinib is convenient for patients, allowing for easier adherence to treatment regimens.
• Fewer Side Effects: Many patients experience fewer and less severe side effects compared to conventional chemotherapy, improving their quality of life during treatment.
• Rapid Response: Some patients may experience a rapid reduction in tumor size and symptoms, leading to quicker relief.

Contraindications of Gefitinib

Gefitinib should be avoided in certain populations, including:

• Pregnant or Breastfeeding Women: The effects on fetal development are not well-studied, and it may pose risks to the baby.
• Patients with Severe Liver Disease: Those with significant liver impairment may not metabolize gefitinib properly, leading to increased toxicity.
• Allergic Reactions: Individuals with a known hypersensitivity to gefitinib or any of its components should not use this medication.

Precautions and Warnings

Before starting gefitinib, patients should undergo specific evaluations, including:

• Liver Function Tests: Regular monitoring of liver enzymes is essential to detect any potential liver issues early.
• Pulmonary Function Tests: Patients should be monitored for new or worsening respiratory symptoms, as gefitinib can rarely cause interstitial lung disease.
• Skin Assessments: Monitoring for skin reactions is important, as severe rashes can occur.

Patients should also be advised to report any new or worsening symptoms, particularly respiratory issues or skin changes.

FAQs

• What is gefitinib used for? Gefitinib is primarily used to treat non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations.
• How should I take gefitinib? Take gefitinib as prescribed, usually 250 mg once daily, with a full glass of water.
• What are the common side effects? Common side effects include diarrhea, skin rash, nausea, and fatigue.
• Can I take other medications with gefitinib? Some medications can interact with gefitinib. Always inform your doctor about all medications you are taking.
• Is gefitinib safe during pregnancy? Gefitinib is not recommended during pregnancy due to potential risks to the fetus.
• How does gefitinib work? Gefitinib blocks the epidermal growth factor receptor (EGFR), slowing down cancer cell growth.
• What should I do if I miss a dose? If you miss a dose, take it as soon as you remember. If it's close to the next dose, skip the missed dose and continue with your regular schedule.
• Can I drink alcohol while taking gefitinib? It's best to limit alcohol consumption, as it may increase the risk of liver problems.
• How long will I need to take gefitinib? The duration of treatment varies based on individual response and disease progression. Your doctor will guide you.
• What should I do if I experience severe side effects? Contact your healthcare provider immediately if you experience severe side effects or any unusual symptoms.

Brand Names

Gefitinib is marketed under several brand names, including: Iressa

Conclusion

Gefitinib represents a significant advancement in the treatment of non-small cell lung cancer, particularly for patients with specific EGFR mutations. Its targeted mechanism of action, oral administration, and favorable side effect profile make it a valuable option in oncology. However, careful monitoring and consideration of contraindications are essential to ensure patient safety and treatment efficacy. Always consult with a healthcare provider for personalized medical advice and treatment plans.